Browsing by Author Zhang, Wanggang
Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
1-Jan-2021 | Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study | Zhang, Li; Meng, Li; Liu, Bingcheng; Zhang, Yanli; Zhu, Huanling; Cui, Jiuwei; Sun, Aining; Hu, Yu; Jin, Jie; Jiang, Hao; Zhang, Xi; Li, Yan; Liu, Li; Zhang, Wanggang; Liu, Xiaoli; Gu, Jian; Qiao, Jianhui; Ouyang, Guifang; Liu, Xin; Luo, Jianmin; Jiang, Ming; Xie, Xiaobao; Li, Jianyong; Zhao, Chunting; Zhang, Mei; Yang, Tonghua; Wang, Jianxiang |
2019 | Frontline flumatinib versus imatinib in patients with chronic myeloid leukemia in chronic phase: Results from the China randomized phase III study. | Li, Zhang; Meng, Li; Zhang, Yanli; Zhu, Huanling; Cui, Jiuwei; Sun, Aining; Hu, Yu; Jin, Jie; Jiang, Hao; Zhang, Xi; Li, Yan; Liu, Qifa; Liu, Li; Zhang, Wanggang; Gu, Jian; Qiao, Jian-Hui; Liu, Bingcheng; Zhang, Fengkui; Guo, Yong; Wang, Jianxiang |